| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.0022 | 0.9 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | 0.0056 | 0.9 |
| mRNA | NSC-87877 | GDSC1000 | pan-cancer | AAC | 0.0025 | 0.9 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | 0.0029 | 0.9 |
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | -0.0025 | 0.9 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | 0.0023 | 0.9 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.0029 | 0.9 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | -0.0026 | 0.9 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | -0.0063 | 1 |